George W. Sledge

发表

Susan G. Komen Big Data for Breast Cancer Initiative: How Patient Advocacy Organizations Can Facilitate Using Big Data to Improve Patient Outcomes

Jerome Jourquin, Stephanie Birkey Reffey, Cheryl Jernigan, 2019, JCO precision oncology.

Synergistic drug combinations from electronic health records and gene expression

Maya B. Mathur, Trevor J. Hastie, Nigam H. Shah, 2016, J. Am. Medical Informatics Assoc..

Using natural language processing to construct a metastatic breast cancer cohort from linked cancer registry and electronic medical records data pdf

Nigam H. Shah, George W. Sledge, Allison W. Kurian, 2019, JAMIA open.

Improving the quality of cancer care in America through health information technology

George W. Sledge, Thomas W. Feeley, Laura Levit, 2014, J. Am. Medical Informatics Assoc..

Buildings and Facilities for Vocational Agriculture/Agribusiness Departments.

George W. Sledge, 1980 .

Triple-Negative Breast Cancer: Risk Factors to Potential Targets

Charles M. Perou, George W. Sledge, Andrea Richardson, 2008, Clinical Cancer Research.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Y Wang, Mike Clarke, Donald A. Berry, 2005, The Lancet.

Classification of large circulating tumor cells isolated with ultra-high throughput microfluidic Vortex technology

Rajan P Kulkarni, Dino Di Carlo, James Che, 2016, Oncotarget.

Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity

George W. Sledge, Harikrishna Nakshatri, Sunil Badve, 2013, Scientific Reports.

Decade in review—targeted therapy: Successes, toxicities and challenges in solid tumours

George W. Sledge, Joel W. Neal, G. Sledge, 2014, Nature Reviews Clinical Oncology.

Virtual screening targeting the urokinase receptor, biochemical and cell-based studies, synthesis, pharmacokinetic characterization, and effect on breast tumor metastasis.

Jing Li, George W. Sledge, Samy O. Meroueh, 2011, Journal of medicinal chemistry.

A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast

George W. Sledge, David L. Page, Robert Gray, 2013, Journal of the National Cancer Institute.

Abstract GS6-03: Circulating tumor cells (CTCs) five years after diagnosis are prognostic for late recurrence in operable stage II-III breast cancer

George W. Sledge, Antonio C. Wolff, Kathy D. Miller, 2018 .

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.

Molin Wang, George W. Sledge, Antonio C. Wolff, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of Computational Algorithms for the Classification of Liver Cancer using SELDI Mass Spectrometry: A Case Study

George W. Sledge, Changyu Shen, Kathy D. Miller, 2007, Cancer informatics.